Get the Stockscreener App
3.155
0.48%
0.015
After Hours:
3.15
-0.005
-0.16%
Theratechnologies Inc stock is traded at $3.155, with a volume of 180.97K.
It is up +0.48% in the last 24 hours and up +24.70% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$3.14
Open:
$3.14
24h Volume:
180.97K
Relative Volume:
0.32
Market Cap:
$145.07M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-63.10
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
+0.48%
1M Performance:
+24.70%
6M Performance:
+83.97%
1Y Performance:
+102.24%
1-Day Range:
$3.14
$3.16
1-Week Range:
$3.14
$3.16
52-Week Range:
$1.12
$3.20
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
3.155 | 144.38M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
What analysts say about Theratechnologies Inc. stockDouble-digit growth - jammulinksnews.com
Theratechnologies Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - jammulinksnews.com
Is Theratechnologies Inc. a good long term investmentOutstanding risk-reward balance - Autocar Professional
How to Take Advantage of moves in (TH) (TH:CA) - news.stocktradersdaily.com
Theratechnologies to Hold Special Shareholder Meeting in September 2025 - AInvest
What drives Theratechnologies Inc. stock priceFree Consultation - jammulinksnews.com
Theratechnologies Reports Financial Results for the Second Quarter 2025 - ADVFN Brasil
Theratechnologies Announces Special Shareholder Meeting for September 2025 - TipRanks
A Look at Theratechnologies's Upcoming Earnings Report - 富途牛牛
Theratechnologies Shares Surge 34% After $254 Million Acquisition Announcement - MSN
Theratechnologies Announces Acquisition Agreement with CB Biotechnology - The Globe and Mail
Theratechnologies Reports Q2 2025 Financial Results and Acquisition Agreement - TipRanks
Theratechnologies stock holds steady as Jones Trading maintains rating - Investing.com Australia
Theratechnologies Reports Q2 2025 Earnings and Acquisition - The Globe and Mail
Theratechnologies Inc (NASDAQ:THTX) Revenue Declines - FXDailyReport.Com
When (TH) Moves Investors should Listen (TH:CA) - news.stocktradersdaily.com
Theratechnologies stock holds steady as Jones Trading maintains rating By Investing.com - Investing.com Nigeria
Theratechnologies: Fiscal Q2 Earnings Snapshot - CTPost
Theratechnologies to be bought by CB Biotechnology for $254M - MSN
Theratechnologies Inc reports results for the quarter ended May 31Earnings Summary - TradingView
MBRX gains RAMPA nod for pivotal Phase 2B/3 AnnAraC AML trial | THTX SEC FilingForm 6-K - Stock Titan
THTX Sees Strong Demand for EGRIFTA SV, Anticipates Growth | TH - GuruFocus
What To Expect From Theratechnologies Inc (TSX:TH) Q2 2025 Earni - GuruFocus
Theratechnologies' Pending Sale to Future Pak - Cleary Gottlieb
What To Expect From Theratechnologies Inc (TSX:TH) Q2 2025 Earnings - Yahoo Finance
(TH) Technical Pivots with Risk Controls (TH:CA) - news.stocktradersdaily.com
Beyond GLP-1s: Is Tesamorelin’s Exit A Sign Of New Metabolic Opportunities? (NASDAQ:THTX) - Seeking Alpha
Theratechnologies: Beyond GLP-1sIs Tesamorelin's Exit A Sign Of New Metabolic Opportunities? - Seeking Alpha
Theratechnologies THTX 2025Q2 Earnings Preview Upside Potential Driven by Robust EPS Growth - AInvest
TSX Small Cap Index Rises as Theratechnologies Advances on Acquisition Agreement - Kalkine Media
(TH) Daily Stock Insights (TH:CA) - news.stocktradersdaily.com
Future Pak to buy Theratechnologies for $254 million - The Pharma Letter
Small caps to watch: Biopharm stock surges on takeover deal, Cargojet wins contract extension, and more - The Globe and Mail
Theratechnologies shareholders should take the deal, Research Capital says - Cantech Letter
Theratechnologies to Announce Second Quarter 2025 Financial Results - The Manila Times
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sector Update: Health Care - MarketScreener
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):